The Protective Effect of Ebselen on Radiocontrast-Induced Nephrotoxicity

被引:19
|
作者
Ozgur, Tumay [1 ]
Tutanc, Murat [2 ]
Zararsiz, Ismail [3 ]
Motor, Sedat [4 ]
Ozturk, Oktay Hasan [4 ]
Yaldiz, Mehmet [1 ]
Kurtgoz, Ozgur Yildirim [4 ]
机构
[1] Mustafa Kemal Univ, Dept Pathol, Sch Med, TR-31100 Antakya, Hatay, Turkey
[2] Mustafa Kemal Univ, Dept Pediat, Sch Med, TR-31100 Antakya, Hatay, Turkey
[3] Mevlana Univ, Dept Anat, Sch Med, Konya, Turkey
[4] Mustafa Kemal Univ, Dept Biochem, Sch Med, TR-31100 Antakya, Hatay, Turkey
关键词
radiocontrast; ebselen; nephrotoxicity; protective effect; rats; CONTRAST-MEDIA; N-ACETYLCYSTEINE; INDUCED NEPHROPATHY; SODIUM-BICARBONATE; RENAL DAMAGE; PREVENTION; ANTIOXIDANT; ERDOSTEINE; MECHANISMS; CISPLATIN;
D O I
10.3109/0886022X.2012.706880
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim: Radiocontrast-induced nephropathy has become one of the most important causes of renal acute failure. The most effective management of reducing the incidence of contrast nephropathy is to understand and prevent its causes. We aimed to investigate the protective role of ebselen against radiocontrast-induced nephrotoxicity in terms of tissue oxidant/antioxidant parameters and light microscopy in rats. Methods: Albino Wistar rats were randomly separated into four groups. The Group 1 rats were treated with sodium chloride as the control group, Group 2 with radiocontrast, Group 3 with radiocontrast plus ebselen, and Group 4 with ebselen alone. After 24 h, the animals over the experimental period were euthanized and blood samples were analyzed for blood urea nitrogen (BUN) and serum creatinine (Cr) levels. Kidney sections were analyzed for malondialdehyde (MDA) levels and superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GSH-Px) activities, as well as histopathological changes. Results: In the radiocontrast group, BUN, MDA, and GSH-Px levels increased while SOD activity decreased compared with the control group. These decays were improved by ebselen administration in the radiocontrast group. Significant histological deteriorations were observed in the radiocontrast group. We noted improvement in the histologic findings with ebselen administration. Conclusion: These results indicate that ebselen might produce a protective mechanism against radiocontrast-induced nephrotoxicity.
引用
收藏
页码:991 / 997
页数:7
相关论文
共 50 条
  • [1] The Protective Effect of Erdosteine on Radiocontrast Induced Nephrotoxicity in Rats
    Yesilyurt, Ahmet
    Erden, Ismail Aydin
    Bilgic, Ismail
    Erden, Gonul
    Albayrak, Aynur
    ENVIRONMENTAL TOXICOLOGY, 2011, 26 (04) : 395 - 402
  • [2] RADIOCONTRAST-INDUCED NEPHROPATHY
    PORTER, GA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 : 146 - 156
  • [3] RADIOCONTRAST-INDUCED NEPHROTOXICITY (RCIN) IN DOGS WITH EXPERIMENTAL HEART-FAILURE
    MARGULIES, KB
    BURNETT, JC
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 489 - 489
  • [4] Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670
    Brooks, DP
    DePalma, PD
    NEPHRON, 1996, 72 (04): : 629 - 636
  • [5] Radiocontrast-induced nephropathy
    Solomon, R
    SEMINARS IN NEPHROLOGY, 1998, 18 (05) : 551 - 557
  • [6] Protective effect of erythropoietin against radiocontrast-induced renal tubular epithelial cell injury
    Kolyada, Alexey Y.
    Liangos, Orfeas
    Madias, Nicolaos E.
    Jaber, Bertrand L.
    AMERICAN JOURNAL OF NEPHROLOGY, 2008, 28 (02) : 203 - 209
  • [7] Radiocontrast-Induced Thyroid Storm
    Thumma, Soumya
    Manchala, Venkata
    Mattana, Joseph
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (05) : E644 - E645
  • [8] Prevention of radiocontrast-induced nephropathy
    Asif, A
    Epstein, M
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (01) : 12 - 24
  • [9] A primer in radiocontrast-induced nephropathy
    Krämer, BK
    Kammerl, M
    Schweda, F
    Schreiber, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (12) : 2830 - 2834
  • [10] Prevention of radiocontrast-induced nephropathy
    Baker, CSR
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 58 (04) : 532 - 538